Cargando…
Wildtype and A30P Mutant Alpha-Synuclein Form Different Fibril Structures
Parkinson’s Disease (PD) is a neurodegenerative movement disorder affecting millions of people worldwide. One of the key players in the development of the disease is the protein α-synuclein (aSN), which aggregates in the brain of PD patients. The aSN mutant A30P has been reported to cause early-onse...
Autores principales: | Nielsen, Søren Bang, Macchi, Francesca, Raccosta, Samuele, Langkilde, Annette Eva, Giehm, Lise, Kyrsting, Anders, Svane, Anna Sigrid Pii, Manno, Mauro, Christiansen, Gunna, Nielsen, Niels Christian, Oddershede, Lene, Vestergaard, Bente, Otzen, Daniel Erik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3701545/ https://www.ncbi.nlm.nih.gov/pubmed/23861789 http://dx.doi.org/10.1371/journal.pone.0067713 |
Ejemplares similares
-
A monomer-trimer model supports intermittent glucagon fibril growth
por: Košmrlj, Andrej, et al.
Publicado: (2015) -
Reducing the Amyloidogenicity of Functional Amyloid
Protein FapC Increases Its Ability To Inhibit α-Synuclein
Fibrillation
por: Christensen, Line Friis Bakmann, et al.
Publicado: (2019) -
Two conformationally distinct α-synuclein oligomers share common epitopes and the ability to impair long-term potentiation
por: van Diggelen, Femke, et al.
Publicado: (2019) -
Structural
Basis for Dityrosine-Mediated Inhibition
of α-Synuclein Fibrillization
por: Sahin, Cagla, et al.
Publicado: (2022) -
Functional bacterial amyloid increases Pseudomonas biofilm hydrophobicity and stiffness
por: Zeng, Guanghong, et al.
Publicado: (2015)